J&J to pay $158 million to settle Texas Risperdal case Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal anti-psychotic drug to state residents on the Medicaid health program for the poor
How to help a friend with an eating disorder Reaching out to a friend or loved one that you suspect is suffering from an eating disorder can be scary, but it is imperative that you speak up.
Stoned driving epidemic puts wrinkle in Marijuana debate Angeline Chilton says she can't drive unless she smokes pot.
Fake drugs hard to spot amid 1,800 wholesalers Stamping out trade in counterfeit drugs like Roche's Avastin is an uphill fight for regulators, whose task is complicated by the presence of thousands of small wholesalers across Europe